Domov › Chronická lymfocytová leukémia › Kolumbijský okres › Washington
Klinické štúdie Chronická lymfocytová leukémia v meste Washington, DC
22 štúdií pre Chronická lymfocytová leukémia hľadá účastníkov v zariadeniach v meste Washington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Prebieha náborFáza 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 míľ odtiaľ
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Prebieha náborFáza 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 7 míľ odtiaľ
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Prebieha náborFáza 3
- GC2202 Study Site 111, Bethesda · 7 míľ odtiaľ
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Prebieha náborFáza 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Prebieha náborFáza 3
- American Oncology Partners of Maryland Pa, Bethesda · 7 míľ odtiaľ
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Prebieha náborFáza 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Prebieha náborFáza 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 míľ odtiaľ
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Prebieha náborFáza 2
- Maryland Oncology Hematology, Silver Spring · 7 míľ odtiaľ
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Prebieha náborSkorá fáza 1
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Prebieha náborFáza 3
- American Oncology Partners of Maryland, PA, Bethesda · 7 míľ odtiaľ
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Prebieha náborFáza 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 7 míľ odtiaľ
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
Prebieha náborFáza 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Prebieha náborFáza 1
- National Institute of Health, Bethesda · 7 míľ odtiaľ
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Prebieha náborFáza 2
- American Oncology Partners, PA, Bethesda · 7 míľ odtiaľ
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Prebieha náborFáza 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 7 míľ odtiaľ
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 7 míľ odtiaľ
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Prebieha náborFáza 1
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Štúdie Chronická lymfocytová leukémia v iných mestách
- Boston, MA31 štúdií
- Columbus, OH28 štúdií
- Durham, NC27 štúdií
- Seattle, WA20 štúdií
- Rochester, MN18 štúdií
- New York City, NY18 štúdií
- Houston, TX17 štúdií
- Baldwin Park, CA16 štúdií
- Milwaukee, WI15 štúdií
- Chicago, IL14 štúdií
- Cincinnati, OH14 štúdií
- Nashville, TN13 štúdií
Iné štúdie v Washington
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc55 štúdií
- Rakovina prsníka46 štúdií
- Metastatická rakovina43 štúdií
- Rakovina pľúc41 štúdií
- Rakovina prostaty38 štúdií
- Obézita33 štúdií
- Kolorektálny karcinóm29 štúdií
- Kardiovaskulárne ochorenia28 štúdií
- Rakovina močového mechúra26 štúdií
- Akútna myeloidná leukémia24 štúdií
- Rakovina vaječníkov23 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.